Topic: Sports cardiology Introduction The role of VPBs in competitive athletes is an issue of concern for sport cardiology practitioners. Isolated ventricular premature beats (VPBs) are commonly found during pre-participation screening in athletes. Currently the debate about the role of detraining in reducing the number of VPBs is still open. Purpose We evaluated the arrhythmic risk in a population of young competitive athletes who showed VPBs during eligibility evaluation and that did not undergo detraining but continued practicing competitive sports. Methods This is a retrospective longitudinal study. A population of 3746 consecutive subjects underwent pre-participation screening at our Center. In accordance with the Italian screening program athletes who showed VPBs were selected and underwent second level evaluation (Echocardiogram, 24h Holter ECG and Exercise test). Athletes were re-evaluated after a follow-up period (6-120 months) while they continued practicing competitive sports. We selected the athletes who met the following inclusion criteria: 1) aged 18-45, 2) both genders, 3) practising competitive sports, 4) more than 2 VPBs per 10s tracking ECG, 5) serial (!2) 24h-holter ECG records; exclusion criteria were: 1) sustained ventricular tachycardia, 2) cardiomyopathy known, 3) family history positive for sudden death, 4) incomplete cardiologic second level evaluation. Results From the whole population who underwent pre-participation screening at our Centre (n.3746) we found 199 athletes who showed VPBs (5,3% of the whole population). On the basis of inclusion and exclusion criteria, we defined a selected population of 106 competitive athletes both male (n.68) and female (n.38), mean age 22 AE 5 years. 77% of the subjects showed isolated VPBs, 88% of the subjects showed monomorphic VPBs. The most frequent morphology was RVOT (44,3%), then LVOT (23,6) Fascicular (17%) and other morphology less frequently (15,1%). At echocardiogram there was not any pathology which contraindicated competitive sport activity. At first 24h Holter ECG evaluation mean number of daily VPBs was 1592 AE 3217 (range 0-16678). At Holter ECG follow-up (24AE22 months) the median number of VPBs decreased significantly from 93 (IQR 20-3065) to a new value of 10 (IQR 1-587). All the athletes continued to train during the follow-up period, practicing competitive sports. Conclusion As known from clinical practise, the discovery of VPBs constitutes a clinical dilemma when deciding on eligibility for sport. We can confirm that continuing sport activities, also at a competitive level, in subjects without structural cardiomyopathy, who show ventricular arrhythmias even though frequent but with a low grade of complexity, do not increase sudden death risk and have a late-midterm benign prognostic significance.
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